"Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Haemophilia B patients with factor IX inhibitors have particularly unmet needs for conventional therapy. Click to show full abstract

Haemophilia B patients with factor IX inhibitors have particularly unmet needs for conventional therapy.

Keywords: haemophilia patients; factor viia; factor; derived factor; plasma derived; haemophilia

Journal Title: Haemophilia
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended